Globuline, immune privigen 5GM
Ended Awarded
- Contract number
- 36C24819F0093
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $79,339
Award facts
- Contract value 100% obligated
- $79,338.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price BPA call order issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a large foreign-owned for-profit biotherapeutics company, for the provision of GLOBULINE, IMMUNE PRIVIGEN 5GM, a plasma-derived pharmaceutical product, valued at $79,338.60. The order was placed against CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a total ceiling value of $201,482,280 and is valid through September 2026. This BPA call order does not have a set-aside designation, reflecting CSL Behring's status as a large enterprise. The contract supports the VA's provision of critical medical treatments to veteran healthcare programs across different regional Veterans Integrated Service Networks (VISNs).
Quick answers
Who was awarded contract 36C24819F0093?
36C24819F0093 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 8 (Veterans Health Administration) on November 20, 2018.
How much is contract 36C24819F0093 worth?
The government has obligated $79,339 on 36C24819F0093.
Is contract 36C24819F0093 an order under another contract?
Yes. 36C24819F0093 is a BPA call under V797D50358-VA24816A0004, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24819F0093 competed?
The extent of competition for 36C24819F0093 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award